[1] Ali F S, Nguyen M H, Hernaez R, et al. AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals[J]. Gastroenterology, 2025, 168(2):267-284. [2] European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection[J]. J Hepatol, 2025, 83(2):502-583. [3] Pan C Q, Dai E, Mo Z, et al. Tenofovir and hepatitis B virus transmission during pregnancy: a randomized clinical trial[J]. JAMA, 2025, 333(5):390-399. [4] Taye B W, Ayenew G M, Wasie Taye Z, et al. The risk of mother-to-child transmission of hepatitis B virus infection in Ethiopia: a systematic review and meta-analysis[J]. J Infect Dev Ctries, 2023, 17(6):744-751. [5] Matthews P C, Ocama P, Wang S, et al. Enhancing interventions for prevention of mother-to-child-transmission of hepatitis B virus[J]. JHEP Rep, 2023, 5(8):100777. [6] Arefaine M, Johannessen A, Teklehaymanot T, et al. A prospective, multicenter study of hepatitis B birth-dose vaccine with or without hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus in Ethiopia[J]. Vaccine, 2024, 42(26):126461. [7] Tang J, Zhao H. Concerns on the mother-to-child transmission of hepatitis B virus reported in Ethiopia[J]. J Infect Dev Ctries, 2024, 18(11):1780-1781. [8] Luo Y L, Gao S, Zhang Q F, et al. Eliminating mother-to-child transmission of hepatitis B virus: practice and progress in Baoan, a national pilot district of China[J]. BMC Public Health, 2024, 24(1):58. [9] Funk A L, Lu Y, Yoshida K, et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2021, 21(1):70-84. [10] Zeleke E D, Assefa D G, Joseph M, et al. Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis of randomised control trials[J]. Rev Med Virol, 2021, 31(5):1-16. [11] Leung W C, Wong M C S. Can we eliminate mother-to-child transmission of hepatitis B virus in Hong Kong by 2030?[J]. Hong Kong Med J, 2024, 30(5):350-351. [12] Alleman M M, Sereno L S, Whittembury A, et al. Progress toward elimination of mother-to-child transmission of hepatitis B virus-region of the Americas, 2012-2022[J]. MMWR Morb Mortal Wkly Rep, 2024, 73(29):648-655. [13] Du X, Zhang L, Liu Z, et al. Risk of mother-to-child transmission after amniocentesis in pregnant women with hepatitis B virus: a retrospective cohort study[J]. Am J Obstet Gynecol, 2024, 230(2):249.e1-249.e8. [14] Al Awaidy S, Tohme R A, Al Romaihi H E, et al. Elimination of mother-to-child transmission of hepatitis B virus in gulf cooperation council countries: current status and future prospects[J]. Am J Trop Med Hyg, 2023, 110(1):32-35. [15] Zhou J, Zhang P, Tan Z, et al. Results of mother-to-child transmission in hepatitis B-positive mothers who underwent amniocentesis[J]. BMC Infect Dis, 2024, 24(1):957. [16] Gu J, Xu Y, Yuan J, et al. Investigation of mother-to-child transmission of hepatitis B in Yinchuan, China: cross-sectional survey study[J]. JMIR Public Health Surveill, 2024, 10:e60021. [17] Han D, Du J, Wang W, et al. Evaluation of the efficacy and safety of tenofovir disoproxil fumarate in intercepting mother-to-child transmission of hepatitis B virus[J]. Acta Med Okayama, 2024, 78(2):107-113. [18] Nguyen H T, Chaikledkaew U, Hoang M V, et al. Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country[J]. BMC Health Serv Res, 2024, 24(1):1658. [19] Pan C Q, Zhu L, Yu A S, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate for preventing vertical transmission in chronic hepatitis B mothers: a systematic review and meta-analysis[J]. Clin Infect Dis, 2024, 79(4):953-964. [20] Hoang Q C, Nguyen M N, Nguyen T T H, et al. Mother-to-child transmission of HBV infection by preventive interventions in Southern Vietnam's hospitals[J]. J Public Health Manag Pract, 2024, 30(2):213-220. |